Researchers at San Carlos Clinical Hospital in Madrid may have targeted potential solutions For hair removal.
A recent study analyzed the effects of injections Mouse Skin Human fat stem cells – “Adipoce-derived stem cells (ASCS)” – as a means of treating androgenic alopecia (AGA), more commonly known as male or female pattern hair loss.
The team discovered that male mice received low doses of ASC and then achieved the best hair regrowth three weeks after combining an energy-enhancing molecule called adenosine triphosphate (ATP).
Hairstylists and medical professionals check for temporary hair removal affecting Ozempic users
Low- and high-dose ASC treatment along with ATP did not result in regrowth of women’s hair, while medium-duty ASC and ATP led to greater regrowth.
Researcher We concluded that hair regrowth improved in “all experimental groups” where male mice received ATP-supplemented stem cell solutions.
The findings were published in Journal Stem Cell Research & Therapy.
Principal Research Author Dr. Eduardo Lopez Blanc – a dermatologist and professor at Comprotense University in Madrid – shared his expectations for the research in an interview with Fox News Digital.
This daily beauty routine can be ruining your hair, experts warn
“We were hoping for good results, but it wasn’t that high level of success,” he said. “We’re talking about very high hair regeneration in both male and female mice.”
At the appropriate dose, the researchers achieved a “very high percentage” of hair regrowth, pointing out 100% of male mice and up to 90% of female mice hair.
“These results indicate that advanced therapies may represent new therapeutic approaches to many diseases that are currently unavailable,” continued Blanc.
“Achieve such promising results Preclinical phase A completely novel approach to andro-hereditary alopecia (those that avoid chronic treatment and safe) is an important scientific milestone. ”
A major limitation of this study was the thinness of the skin in mice, Blanc noted.
“This requires the development of protocols to minimize experimental variability, and is a key factor when human research begins,” he said.
These new discoveries “should be interpreted with caution and scientific rigor,” warned Blanc.
“While mouse results represent a huge advancement, it is also true that it is essential to wait for human clinical benefits to be confirmed.”
Click here to sign up for our health newsletter
Researchers encouraged people with androgenic alopecia to continue consultations with dermatologists and follow Prescribed treatment As research develops.
“It’s important to maintain hope. Research advances point to solutions that could provide long-term outcomes without the need for ongoing treatment to maintain profits in the future,” Bran added.
Researchers are looking forward to human clinical trials and are “actively working” to check the safety of men with moderate andro-hereditary alopecia and 50-year-old men, the researchers noted.
“If everything goes as expected, the most optimistic timeline shows that treatment will be available in about five years,” he said.
In another interview with Fox News Digital, Dr. Brendan Camp, a New York-based dermatologist, commented on the potential of this method.
“Although not commercially available, this study suggests that injections of stem cells added to scalp skin supplemented with ATP may potentially promote hair regeneration in individuals with androgenic alopecia,” he reiterated.
Visit us for more health articles www.foxnews.com/health.
“This study is small and this method requires more research as a potential treatment option for androgenic alopecia.”
Until then, camping will deal with hair removal. Board Certified Dermatologist For evaluation.
